Bio-Techne Corp Z Score vs. Cash Flow From Operations

TE1 Stock   72.00  0.50  0.70%   
Considering Bio-Techne Corp's profitability and operating efficiency indicators, Bio Techne Corp may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in February. Profitability indicators assess Bio-Techne Corp's ability to earn profits and add value for shareholders.
For Bio-Techne Corp profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Bio-Techne Corp to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Bio Techne Corp utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Bio-Techne Corp's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Bio Techne Corp over time as well as its relative position and ranking within its peers.
  
Check out World Market Map.
For more information on how to buy Bio-Techne Stock please use our How to Invest in Bio-Techne Corp guide.
Please note, there is a significant difference between Bio-Techne Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio-Techne Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio-Techne Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Bio Techne Corp Cash Flow From Operations vs. Z Score Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Bio-Techne Corp's current stock value. Our valuation model uses many indicators to compare Bio-Techne Corp value to that of its competitors to determine the firm's financial worth.
Bio Techne Corp is rated second in z score category among its peers. It is rated third in cash flow from operations category among its peers making about  8,213,939  of Cash Flow From Operations per Z Score. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bio-Techne Corp's earnings, one of the primary drivers of an investment's value.

Bio-Techne Cash Flow From Operations vs. Z Score

Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..

Bio-Techne Corp

Z Score

 = 

Sum Of

5 Factors

 = 
39.6
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.

Bio-Techne Corp

Operating Cash Flow

 = 

EBITDA

-

Taxes

 = 
325.27 M
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.

Bio-Techne Cash Flow From Operations Comparison

Bio Techne is currently under evaluation in cash flow from operations category among its peers.

Bio-Techne Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Bio-Techne Corp. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Bio-Techne Corp position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Bio-Techne Corp's important profitability drivers and their relationship over time.

Use Bio-Techne Corp in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bio-Techne Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio-Techne Corp will appreciate offsetting losses from the drop in the long position's value.

Bio-Techne Corp Pair Trading

Bio Techne Corp Pair Trading Analysis

The ability to find closely correlated positions to Bio-Techne Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bio-Techne Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bio-Techne Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bio Techne Corp to buy it.
The correlation of Bio-Techne Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bio-Techne Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bio Techne Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bio-Techne Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Bio-Techne Corp position

In addition to having Bio-Techne Corp in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Candy and Soda Thematic Idea Now

Candy and Soda
Candy and Soda Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Candy and Soda theme has 13 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Candy and Soda Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Bio-Techne Stock Analysis

When running Bio-Techne Corp's price analysis, check to measure Bio-Techne Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio-Techne Corp is operating at the current time. Most of Bio-Techne Corp's value examination focuses on studying past and present price action to predict the probability of Bio-Techne Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio-Techne Corp's price. Additionally, you may evaluate how the addition of Bio-Techne Corp to your portfolios can decrease your overall portfolio volatility.